Large-Scale HIV Vaccine Trial to Launch in South Africa

An early-stage HIV vaccine clinical trial in South Africa has determined that an investigational vaccine regimen is safe and generates comparable immune responses to those reported in a landmark 2009 study showing that a vaccine can protect people from HIV infection. Consequently, the National Institute of Allergy and Infectious Diseases (NIAID) and its partners have […]http://feedproxy.google.com/~r/Appa-sourceTheAfric...